CompaniesNovelix Pharmaceuticals

Novelix Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

1

As Collaborator

3

Total Enrollment

541

By Phase

PHASE2: 2PHASE1: 1

By Status

COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details

Recent Trials

NCT06573190Collaborator
Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B
N/ACompleted
70 participants
Started: Jan 2, 2023 · Completed: May 15, 2024
NCT04962893Collaborator
Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine
PHASE2Completed
349 participants
Started: Jun 26, 2021 · Completed: Jan 16, 2022
NCT04818281Collaborator
Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults
PHASE1Completed
38 participants
Started: Mar 27, 2021 · Completed: Dec 29, 2021
NCT00483184Lead Sponsor
Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease
PHASE2Completed
84 participants
Started: Apr 30, 2006 · Completed: Apr 30, 2008
Funding History (1)
D
Oct 26, 2009
Filing